Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States
20 October 2017
Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClose™, successfu